No. HT942526RTRPCA · Defense Health Agency Contracting Activity - DHACA
DoW Reconstructive Transplant, Concept Award
Not reimbursement-only
“The funding instrument for awards made under the program announcement will be grants (31 USC 6304).” — From the announcement
- Award range
- Not specified
- Expected awards
- ~3
- Application deadline
- Nov 4, 2026
- Posted
- Jun 17, 2026
- Last verified
- Yesterday
At a glance
AI summaryThis program funds highly innovative, early-stage research in reconstructive transplantation that addresses one of the listed focus areas, such as improving VCA immunosuppression, biomarkers, preservation strategies, or outcome measures. It does not fund clinical trials, and preliminary data are not allowed. Eligible applicants include U.S. Department of War organizations and foreign or domestic, for-profit or nonprofit organizations; investigators at or above the postdoctoral level may serve as principal investigator. The program expects to fund about three awards, with total costs capped at $200,000 per award and a maximum project period of 18 months. Cost sharing is not required, and awards are made to eligible organizations, not individuals.
AI-generated summary — verify against the announcement
What it funds
Official description from grants.gov
Summary: The fiscal year 2026 (FY26) Reconstructive Transplant Research Program (RTRP) Concept Award supports the exploration of highly innovative new concepts or untested theories that address an important problem relevant to reconstructive transplantation. The Concept Award does not support clinical trials . Distinctive Features: · Innovation: Innovative research may introduce a new paradigm, challenge existing paradigms, examine existing problems from new perspectives, or exhibit other highly creative qualities. Research that is an incremental advance upon published data is not considered innovative. · Relevance: Projects should address at least one of the FY26 RTRP Focus Areas. · Preliminary Data: Presentation of preliminary data is not allowed; however, applications should demonstrate the ability to achieve interpretable results. A rationale for the proposed work must be provided. · Early-Career Investigators: Early-career investigators are encouraged to apply. Investigators at or above the level of postdoctoral fellow are eligible to apply.
Who can apply
- Unrestricted
Program history
USASpending.govAssistance listing 12.420 · Military Medical Research and Development
Real awards this federal program has made — the whole assistance listing (12.420), not just this notice.
| Fiscal year | Awards | Median award | Middle half |
|---|---|---|---|
| FY 2026 (so far) | 374 | $934,195 | $559,998 – $1,477,811 |
| FY 2025 | 967 | $796,174 | $416,995 – $1,480,602 |
| FY 2024 | 1,097 | — | — |
| FY 2023 | 1,115 | — | — |
| FY 2022 | 1,186 | — | — |
| FY 2021 | 1,023 | — | — |
Dollar figures are based on the 1,000 most recent awards we store, not all 5,762 — award counts are complete.
- THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER $19,100,256 · FY 2025
- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. $18,696,738 · FY 2025
- UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE $10,606,583 · FY 2025
- SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH $10,500,000 · FY 2026
- UNIVERSITY OF VERMONT & STATE AGRICULTURAL COLLEGE $8,491,997 · FY 2025
Source: USASpending.gov · refreshed Aug 25, 2026
Change history
Since we first indexed it- Aug 27, 2026 Deadline moved: Sep 16, 2026 → Nov 4, 2026